Latest News about Benzinga
Recent news which mentions Benzinga
Cryptocurrency Aave Up More Than 8% In 24 hours
September 10, 2024
From Benzinga
Cryptocurrency Kaspa Rises More Than 4% In 24 hours
September 10, 2024
From Benzinga
Expert Outlook: Arch Capital Group Through The Eyes Of 12 Analysts
September 10, 2024
Tickers
ACGL
From Benzinga
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
September 10, 2024
From Benzinga
$100 Invested In Williams-Sonoma 5 Years Ago Would Be Worth This Much Today
September 10, 2024
From Benzinga
Cryptocurrency Internet Computer Up More Than 7% In 24 hours
September 10, 2024
From Benzinga
Apple Not For You? Check Out 3 Smartphones That Rival The iPhone 16
September 10, 2024
From Benzinga
Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says
September 10, 2024
From Benzinga
Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market
September 10, 2024
From Benzinga
EXCLUSIVE: Magnificent 7 Underperformance, 'Soft Landing' Could Trigger A Rotation Into Small-Cap Stocks, Says Russell Investments' Eitelman
September 10, 2024
From Benzinga
Meta Exemplifies Benefits Of Founder Leadership More Than Any Other Mega Cap Including Nvidia: Analyst
September 10, 2024
From Benzinga
Unpacking the Latest Options Trading Trends in Iris Energy
September 10, 2024
Tickers
IREN
From Benzinga
The Crypto Bros Were Right? How Bitcoin is Becoming an Important Part of the Financial System
September 10, 2024
From Benzinga
Sony's PlayStation 5 Pro to Hit Shelves in November, Boasting 45% Faster Performance
September 10, 2024
From Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $4,700 Today
September 10, 2024
From Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $7,100 Today
September 10, 2024
From Benzinga
Peering Into Willis Towers Watson's Recent Short Interest
September 10, 2024
Tickers
WTW
From Benzinga
Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer
September 10, 2024
From Benzinga
Crude Oil Dips Over 4%; OPEC Cuts Global Oil Demand Outlook
September 10, 2024
From Benzinga
Market Whales and Their Recent Bets on ON Semiconductor Options
September 10, 2024
Tickers
ON
From Benzinga
What's Going On With Boeing Shares Tuesday?
September 10, 2024
From Benzinga
Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage
September 10, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.